FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.
FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
Delawareonline
0 shares
1 views
You might like
Related news coverage
Pfizer Says 3-Dose COVID-19 Vaccine Is Effective For Children Under 5
Newsy
Watch VideoThree doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced..
-
What's next for COVID-19 vaccines for youngest US children
SeattlePI.com
-
Pfizer says 3 COVID shots protect children under 5
SeattlePI.com
-
CDC advisers urge Pfizer booster for children ages 5 to 11
SeattlePI.com
-
Kids 5-11 could start receiving 3rd doses of Pfizer's COVID-19 vaccine within days as CDC advisory committee OKs boosters
USATODAY.com
Advertisement
More coverage
FDA Clears COVID Booster Shot For Healthy Kids Ages 5 To 11
Newsy
Watch VideoU.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine..
-
JAB 'EM YOUNG: FDA approves Pfizer's booster vaccine for children aged 5 to 11 without consulting vaccine advisory panel
NaturalNews.com
-
U.S. FDA clears Pfizer's COVID booster shot for young children
CBC.ca
-
FDA approves Pfizer booster for kids 5-11
CBS 2
-
FDA clears COVID booster shot for healthy kids ages 5 to 11
SeattlePI.com